A Case of Successful Treatment During Migraine Aura Using Isometheptene Compound.
- Author:
Tai Hwan PARK
1
;
Oh Sang KWON
Author Information
1. Department of Neurology, Yong-In Mental Hospital, Yongin, Korea. taihwan@medigate.net
- Publication Type:Case Report
- Keywords:
Migraine;
Aura
- MeSH:
Adult;
Epilepsy*;
Headache;
Humans;
Male;
Migraine Disorders*;
Migraine with Aura;
Tryptamines
- From:Journal of the Korean Neurological Association
2004;22(4):399-401
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Taking medication early on for aborting migraines has proved to be more effective, but trials using triptans during the aura phase have not shown significant effectiveness. Isometheptene compounds are popularly used as an anti-migraine OTC drug. We report a 27-year-old male patient with migraine with aura whose headache attacks were consistently inhibited by an isometheptene compound administered at the early aura phase, while he received no benefits from adequate treatment during the headache phase.
